News and Resources

Study Identifies Potential Nigerian Cohorts for HIV Vaccine Development

A recently-published study conducted by researchers from the U.S. Military HIV Research Program (MHRP) found that high HIV-1 prevalence in two communities in Nigeria, along with a reported high-level of willingness to participate in future HIV intervention studies, indicate favorable epidemiological and logistic conditions for cohort development for HIV vaccine…

2016 WORLD AIDS DAY

The 2016 World AIDS Day in U.S.DOD Walter Reed Program-Nigeria was celebrated in two-fold: Interagency/Embassy level and the USDOD/NMOD Program sites. On site level, 11 USDOD/NMOD Program sites participated in this year’s World AIDS Day (WAD) which targeted the barrack community and its environs.  This year’s theme titled, “Hands on…

JWARG Completes First Training in Nigeria

The Joint West Africa Research Group (JWARG) last week completed its first training, a module on Good Clinical Laboratory Practice. The three-day training in Nigeria included practical sessions, exercises and presentations. It was facilitated by Walter Reed Project-Nigeria PEPFAR lab manager Aminu Suleiman and was attended by participants from Nigeria,…

Joint West Africa Research Group to Foster Biopreparedness

The West African Ebola outbreak highlighted gaps in global public health response and a lack of countermeasures. The DoD invested in a strategic initiative called the Join West Africa Research Group (JWARG) to leverage existing research platforms and relationships to improve biopreparedness in the region. This new program is a…

MHRP, WRAIR Begin New Phase 2 Clinical Trial of Ebola Vaccine Regimens

The Walter Reed Army Institute of Research (WRAIR) today announced the initiation of a Phase 2 clinical trial to evaluate the safety and immunogenicity of a prime-boost Ebola vaccine regimen in both healthy and HIV-infected study volunteers. This study includes two vaccine candidates, Ad26.ZEBOV from Crucell Holland B.V., one of…